Law & Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law & Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
C. R. Bard, Inc.
Court Rules in Favor of Bard on Patent Infringement Suit against W. L. Gore & Associates
August 23rd, 2008
C. R. Bard, Inc. (NYSE: BCR) announced that a U.S. District Court in Arizona entered judgment in Bard's favor in its patent infringement suit against W. L. Gore & Associates. The Court ruled that Gore failed to prove that Bard's patent number 6,436,135 was unenforceable due to inequitable conduct. As previously announced, on December 11, 2007, a jury found that Gore willfully infringed Bard's patent through the sale of Gore's ePTFE vascular grafts and stent-grafts, and awarded Bard $185 million in past damages. Gore may file post-trial motions with the court and may appeal the judgment to the Court of Appeals for the Federal Circuit. C. R. Bard,...
Source: Law & Health Weekly (2008-08-23)
|
